Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 01, 2022

Isatuximab in Patients With Soft-Tissue Plasmacytomas

Leukemia Research


Additional Info

Disclosure statements are available on the authors' profiles:

Leukemia Research
Evaluation of isatuximab in patients with soft-tissue plasmacytomas: an analysis from ICARIA-MM and IKEM
Leuk. Res 2022 Sep 06;[EPub Ahead of Print], M Beksac, I Spicka, R Hajek, et al

Further Reading